High‐throughput cytochrome P450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns
- 11 February 2003
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 17 (6) , 509-518
- https://doi.org/10.1002/rcm.941
Abstract
A generic method employing ultrafast liquid chromatography with tandem mass spectrometry (LC/MS/MS) was developed and employed for routine screening of drug candidates for inhibition of five major human cytochrome P450 (CYP) isozymes, CYP3A4, CYP2D6, CYP2C9, CYP2C19, and CYP1A2. The method utilized a monolithic silica rod column to allow fast flow rates to significantly reduce chromatographic run time. The major metabolites of six CYP-specific probe substrates for the five P450 isoforms were monitored and quantified to determine IC50 values of five drug compounds against each P450 isozyme. Human liver microsomal incubation samples at each test compound concentration were combined and analyzed simultaneously by the LC/MS/MS method. Each pooled sample containing six substrates and an internal standard was separated and detected in only 24 seconds. The combination of ultrafast chromatography and sample pooling techniques has significantly increased sample throughput and shortened assay turnaround time, allowing a large number of compounds to be screened rapidly for potential P450 inhibitory activity, to aid in compound selection and optimization in drug discovery. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high‐performance liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2002
- Introductory remarks on human CYPsDrug Metabolism Reviews, 2002
- High‐speed liquid chromatography/tandem mass spectrometry using a monolithic column for high‐throughput bioanalysisRapid Communications in Mass Spectrometry, 2001
- Direct analysis of pharmaceutical compounds in human plasma with chromatographic resolution using an alkyl‐bonded silica rod columnRapid Communications in Mass Spectrometry, 2001
- High‐throughput cytochrome P450 (CYP) inhibition screening via a cassette probe‐dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1Rapid Communications in Mass Spectrometry, 2001
- Automated 96-Well SPE and LC−MS−MS for Determination of Protease Inhibitors in Plasma and Cartilage TissuesAnalytical Chemistry, 2000
- CYP3A4 drug interactions: correlation of 10 in vitro probe substratesBritish Journal of Clinical Pharmacology, 1999
- SilicaROD™ — A new challenge in fast high-performance liquid chromatography separationsTrAC Trends in Analytical Chemistry, 1998
- Managing the drug discovery/development interfaceDrug Discovery Today, 1997
- Octadecylsilylated Porous Silica Rods as Separation Media for Reversed-Phase Liquid ChromatographyAnalytical Chemistry, 1996